2Ling FC,Baldus SE,Khochfar J,et al.Association of COX-2expression with corresponding active and chronic inflammatory reactions in Barrett′s metaplasia and progression to cancer[J].Histopathology,2007,50(8):203-209.
3Wilson KT,Fu S,Ramanujam KS,et al.Increased expression of inducible nitric oxide synthase and cyclooxygenase-2in Barrett′s esophagus and associated adenocarcinomas[J].CancerRes,1998,58(8):2929-2934.
4Kuramochi H,Vallbohmer D,Uchida K,et al.Quantitative,tissuespecific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett′s adenocarcinoma[J].J Gastrointest Surg,2004,8(10):1007-1017.
6Hamilton JP,Sato F,Jin Z,et al.Reprimo methylation is a potential biomarker of Barrett′s-Associated esophageal neoplastic progression[J].Clin Cancer Res,2006,12(8):6637.
7Lao-Sirieix P,Lovat L,Fitzgerald RC.Cyclin A immunocytology as a risk stratification tool for Barrett′s esophagus surveillance[J].Clin Cancer Res,2007,13(9):659.
2Wang KK,Sampliner RE.Updated guidelines 2008 for the diagnosis,surveillance and therapy of Barrett's esophagus[J].Am J Gastroenterol,2008,103(3):788-797.
4Ferguson DD,DeVault KR.Medical management of gastroesophageal reflux disease[J].Expert Opin Pharmacother,2007,8(1):39-47.
5Ling FC, Baldus SE, Khochfar J, et al. Association of COX-2ex- pression with corresponding active and chronic inflammatory reac- tions in Barrett's meta plasia and progression to cancer[ J]. Histo- pathology ,2007,50( 8 ) :203-209.
